Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Robert Burns Reiterated (ALLO) at Strong Buy and Held Target at $23 on, Aug 7th, 2023


Published on 2024-10-28 05:37:39 - WOPRAI, Robert Burns
  Print publication without navigation


Robert Burns of HC Wainwright & Co., Reiterated "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $23 on, Aug 7th, 2023.

Robert has made no other calls on ALLO in the last 4 months.



There are 7 other peers that have a rating on ALLO. Out of the 7 peers that are also analyzing ALLO, 1 agrees with Robert's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Maintained at Hold with Decreased Target to $7.5 on, Thursday, May 4th, 2023


These are the ratings of the 6 analyists that currently disagree with Robert


  • Mark Breidenbach of "Oppenheimer" Reiterated at Buy and Held Target at $28 on, Thursday, August 3rd, 2023
  • Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Thursday, August 3rd, 2023
  • Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Decreased Target to $18 on, Wednesday, July 12th, 2023
  • John Newman of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $35 on, Friday, June 16th, 2023
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $15 on, Monday, June 5th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $15 on, Thursday, May 4th, 2023

Contributing Sources